Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

@article{Curtis1999RiskOL,
  title={Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.},
  author={R. Curtis and L. Travis and P. Rowlings and G. Soci{\'e} and D. Kingma and P. Banks and E. Jaffe and G. Sale and M. Horowitz and R. Witherspoon and D. A. Shriner and D. Weisdorf and H. Kolb and K. Sullivan and K. Sobocinski and R. Gale and R. Hoover and J. Fraumeni and H. Deeg},
  journal={Blood},
  year={1999},
  volume={94 7},
  pages={
          2208-16
        }
}
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation (BMT) at 235 centers worldwide to examine the incidence of and risk factors for posttransplant lymphoproliferative disorders (PTLD). PTLD developed in 78 recipients, with 64 cases occurring less than 1 year after transplantation. The cumulative incidence of PTLD was 1.0% +/- 0.3% at 10 years. Incidence was highest 1 to 5 months posttransplant (120 cases/10,000 patients/yr) followed by a steep decline to less than… Expand
Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Malignant neoplasms following bone marrow transplantation.
Solid cancers after bone marrow transplantation.
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
  • V. Leblond, F. Davi, +6 authors M. Raphael
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1998
Secondary T-cell lymphoproliferation after marrow transplantation.
...
1
2
3
4
5
...